Close
Nordic 9Nordic 9

Lundbeckfond Ventures (investor - Venture Capital)

Denmark lundbeckfonden.com
See something wrong or missing? Let us know
Offices:Copenhagen

Lundbeckfond Ventures is an evergreen life science venture fund investing in life science companies primarily in Europe, up to €50 million annualy.

Lundbeckfonden Ventures aims to support the group's activities and operating independently from the Lundbeckfonden’s controlling ownerships in H. Lundbeck A/S, ALK-Abelló and Falck.

Average round investment:31.75M USD
Average number per year:2.1
Distribution: 2026 (1)2025 (4)2024 (2)2023 (4)2022 (1) See the entire list
Portfolio companies: Denmark Synuca TherapeuticsDenmark QuantumCellDenmark Kvantify See the entire list
Mostly invests in: Denmark Denmark (19) Biotech (23)
See the entire list

Showing 3 of 25 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Lundbeckfond Ventures mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Lundbeckfond Ventures

Name Criteria
Netherlands Main Capital Partners
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: Denmark, Netherlands, Sweden, France
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Belgium Vives Fund
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Pharma, Manufacturing, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
Denmark Steffen Tjerrild
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Software Services, Hardware, AI (big data)
  • Similar business models: B2B
  • Common investees countries: Denmark, Sweden
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United States Adjuvant Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
France AdBio partners
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Denmark, France, Spain
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
United States Five Elms Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: Sweden, Spain
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
United States Kindred Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.4
  • Active last 12 months: Yes
Sweden HealthCap
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Pharma, Manufacturing, Software Services, Hardware
  • Similar business models: B2B
  • Common investees countries: Denmark, Sweden
  • Average number of deals per year: 2.5
  • Active last 12 months: Yes
Sweden Martin Lorentzon
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
United States Pantera Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: Netherlands, France
  • Average number of deals per year: 2.5
  • Active last 12 months: Yes
Top